P2X receptors in maintenance and differentiation of neural progenitor cells.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Ivermectin exposition during neurulation induces neural tube defects and neuromuscular alterations inFrontiers in pharmacology · 2026
   Article
2. Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder.Frontiers in pharmacology · 2021
   Article
3. Perinatal Brain Injury and Inflammation: Lessons from Experimental Murine Models.Cells · 2020
   Review
4. P2X7 Receptor Signaling in Stress and Depression.International journal of molecular sciences · 2019
   Review
5. Regulation of neural stem/progenitor cell functions by P2X and P2Y receptors.Neural regeneration research · 2017
   Article
6. Connexins and pannexins in neuronal development and adult neurogenesis.BMC cell biology · 2016
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.